ArticleExperimental and therapeutic medicine2018
Radioprotective effect of lactoferrin in mice exposed to sublethal X-ray irradiation.
Article in Experimental and therapeutic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 20 citations in OpenAlex.
- Article
- Features of Brain Damage after Neutron Irradiation of the Head and Modification of the Damage by Lactoferrin.Doklady. Biochemistry and biophysics · 2024Article
- Colostrum Proteins in Protection against Therapy-Induced Injuries in Cancer Chemo- and Radiotherapy: A Comprehensive Review.Biomedicines · 2023Review
- New Properties of a Well-Known Antioxidant: Pleiotropic Effects of Human Lactoferrin in Mice Exposed to Gamma Irradiation in a Sublethal Dose.Antioxidants (Basel, Switzerland) · 2022Article
- Lactoferrin as a Human Genome "Guardian"-An Overall Point of View.International journal of molecular sciences · 2022Review
- Article
- Bovine Lactoferrin Pre-Treatment Induces Intracellular Killing of AIEC LF82 and Reduces Bacteria-Induced DNA Damage in Differentiated Human Enterocytes.International journal of molecular sciences · 2019Article
- Lactoferrin inhibits the proliferation of IMR‑32 neuroblastoma cells even under X‑rays.Medicine internationalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The radioprotective effect of lactoferrin (LF) was studied in mice subjected to sublethal X-ray irradiation. The mice were randomly divided into the Control (non-irradiated mice fed a standard diet without LF), IR (irradiated mice fed a standard diet) and IR+LF (irradiated mice fed LF) groups. The mice were fed daily for 7 days prior to irradiation and for 30 continuous days following irradiation. The survival ratio of the mice in the IR+LF group was significantly increased compared with the IR group between days 15 and 30 after irradiation. The body weight of the mice in the IR+LF group was increased compared with the IR group, and the difference was statistically significant. Blood was collected from the mice via the tail vein on days 2, 7, 14, 21 and 30 following irradiation. The laboratory indicators, including leukocyte, erythrocyte and platelet counts recovered more rapidly following irradiation in the IR+LF group compared with the IR group. Treatment of the irradiated mice with LF significantly reduced the DNA damage. In the hepatic tissue the level of superoxide dismutase in the IR+LF group was significantly increased, while malondialdehyde was significantly decreased compared with the IR group. These findings indicate that LF may prevent radiation damage and may have potential as a treatment for patients with cancer who receive radiotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.